key: cord-0938674-s1jmqdot
authors: Shah, Silvi; Sparks, Matthew A.
title: COVID-19 and the Kidney Community: Coalescing in Crisis
date: 2020-10-26
journal: Adv Chronic Kidney Dis
DOI: 10.1053/j.ackd.2020.10.001
sha: e65ced1a811f5b589b46902a4f834cdc650d9283
doc_id: 938674
cord_uid: s1jmqdot

nan

The coronavirus disease 2019 (COVID-19) pandemic has led to significant changes to kidney medicine. Our ability to provide acute dialysis has strained secondary to the high rates of AKI in patients with COVID-19, occurring in up to 30-40% of hospitalized patients. The presence of AKI in the setting of COVID-19 is associated with high morbidity and mortality. 1 The need for social distancing has resulted in a shift to outpatient telemedicine for many patients with kidney disease. Research findings, hypotheses, and oftentimes rumors and innuendos have spread quickly through various channels of communication including traditional peer reviewed journals, social media, blogs, and preprint servers. Never has the need for accurate and sound science been more important than now. 2 COVID-19 has even altered how we communicate and teach nephrology spanning the spectrum of learners. 3 Virtual learning is more important than ever. Moreover, the virus that causes COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), uses a key enzyme of the renin angiotensin system, angiotensin-converting enzyme 2 (ACE2) to gain entry into host cells. 4 Thus, COVID-19 has become firmly entrenched into nephrology, dominating conversations in social and traditional media, and garnering wide coverage in our journals. The lasting effect of COVID-19 will continue to impact all aspects of kidney care. For example, telehealth had been a discussion point that was tied up in policy and infrastructure issues. 3 In a matter of days, telehealth became commonplace as policy abruptly shifted and technology requirements were dramatically relaxed. Patients with kidney disease, particularly those with end-stage kidney disease (ESKD) undergoing dialysis and individuals receiving immunosuppression (secondary to kidney transplantation or glomerulonephritis) are at a higher risk for severe COVID-19. 5, 6 In the current issue of Advances in Chronic Kidney Disease, we provide an overview of several of the important ways in which COVID-19 has impacted the nephrology community. Hypertension emerged as a potential risk factor for severe COVID-19 early in the pandemic. However, many of these studies did not adjust for age, which represents an important cofounder driving severe COVID-19. One of the links between hypertension and COVID-19 was how SARS-CoV-2 enters host cells through a potent negative regulator of the RAS-ACE2. Thus, putting RAS inhibitors in the spotlight and spurring a debate on whether to start or stop angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Dr.

Edmonston and colleagues review the putative pathophysiology, summarize the literature and recommendations regarding RAS inhibition in COVID-19. 13 With adaptation of social distancing guidelines and increases in clinical demands, the COVID-19 pandemic has affected medical education, for both learners and educators alike. To J o u r n a l P r e -p r o o f optimize medical education in these uncertain times, there has been widespread adaptation to virtual learning platforms, but this comes with its own challenges of limited in-person interaction which is critical for learning. Dr. Hilburg and colleagues discussed the influence of the pandemic on the structure and delivery of medical education. 3 They explore challenges and potential solutions that can be employed in the future with the likely continuation of distant learning. With the exponential rise of information focusing on all aspects of SARS-CoV-2 and COVID-19 posed unique challenges and opportunities. Several grassroots and society-based efforts in the nephrology community were quickly put into place with the goal of providing accurate, vetted, and real time updates. Examples included the NephJC website, the American Society of Nephrology, National Kidney Foundation, among others. 14-16 Importantly, the proliferation of papers and the emergence of preprints during the COVID-19 pandemic provided another challenge. How do we all read and interpret these findings. Dr. Vlasschaert and colleagues summarizes the use of social media during COVID-19 and discusses how preprint servers and pre-publication peer review can be an important part of the scientific discourse. 17 The "Kidney Health and COVID-19" edition of Advances in Chronic Kidney Disease will help guide the nephrology community to determine best practices to prepare for our collective "new normal" in optimizing care for our high-risk patients in the setting of the COVID-19 pandemic.

As we pull together during these times of great uncertainty, it will be our continued responsibility to move the needle forward on the inequities faced by marginalized populations that have been unheeded far too long. We thank the authors and reviewers of the "Kidney 

Acute kidney injury in patients hospitalized with COVID-19

Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19

Medical Education During the Coronavirus Disease-2019 Pandemic: Learning From a Distance

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Covid-19 and Kidney Transplantation

Clinical Characteristics of Coronavirus Disease 2019 in China

Management of Acute Kidney Injury in Coronavirus Disease

COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges

COVID-19 and Kidney Disease Disparities in the United States

COVID-19 pandemic and pregnancy in kidney disease

Policy and Pandemic: The Changing Practice of Nephrology During the Coronavirus Disease-2019 Outbreak

Home Dialysis in the Coronavirus Disease 2019 Era

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System

COVID19

COVID-19 Information

Proliferation of Papers and Preprints during the COVID-19 Pandemic: Progress or Problems with Peer Review? Adv Chronic Kidney Dis Web site